Shares of Acasti Pharma Inc. (CVE:ACST – Get Free Report) traded up 1.8% during trading on Thursday . The stock traded as high as C$0.58 and last traded at C$0.58. 2,450 shares were traded during mid-day trading, a decline of 63% from the average session volume of 6,576 shares. The stock had previously closed at C$0.57.
Acasti Pharma Trading Up 1.8 %
The company has a market cap of C$18.19 million, a PE ratio of -1.21 and a beta of 1.22. The company’s 50 day moving average is C$0.58 and its 200 day moving average is C$0.58.
About Acasti Pharma
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
See Also
- Five stocks we like better than Acasti Pharma
- What is the Dow Jones Industrial Average (DJIA)?
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- 10 Best Airline Stocks to Buy
- DuPont’s Electronics Spinoff: The Start of Something Big
- The Role Economic Reports Play in a Successful Investment Strategy
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
